Search

Home > Foreword

  • VHIO was created in 2006, born out of the necessity to bring together  basic, clinical and translational oncology research activities at the Vall d’Hebron University Hospital campus. VHIO has empowered its scientific programs, increased the number of principal investigators in the basic sciences, increased the number and complexity of its early clinical trials program and also expanded its collaborations with renowned Institutions around the World.
  • These are exciting times in oncology. Our increasing knowledge of the molecular basis of cancer,  together with the availability of novel agents and improved diagnostic methods,  bring the promise of a future drop in mortality due to cancer. At the heart of our mission is to contribute to achieving  these goals and to bring the best cancer care possible to our population. We are in a unique position within VHIO to contribute to this goal.


José Baselga, MD, PhD
Scientific Director